Iterum Therapeutics plc
ITRMDelisted Jun 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659323
Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.
13F holders, Q2 2026
Institutional positions in Iterum Therapeutics plc as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ITRM is no longer listed, and 13F filings after Q1 2026 list far fewer holders. See Q1 2026
- Institutional holders
- 2
- −16 vs. Q1 2026
- Shares held
- 10.9K
- −1.40M (−99.2%) vs. Q1 2026
- Total value
- $542
- −$40.8K (−98.7%) vs. Q1 2026
- New holders
- 1
- 0 more added
- Sold out
- 17
- 0 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ITRM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2 | $542 |
| Q1 2026 | 18 | $41.3K |
| Q4 2025 | 20 | $557.9K |
| Q3 2025 | 24 | $904.1K |
| Q2 2025 | 24 | $2.38M |
| Q1 2025 | 20 | $1.38M |
| Q4 2024 | 24 | $2.18M |
| Q3 2024 | 18 | $2.22M |
| Q2 2024 | 15 | $494.7K |
| Q1 2024 | 18 | $1.43M |
| Q4 2023 | 16 | $761.6K |
| Q3 2023 | 15 | $184.0K |
| Q2 2023 | 17 | $393.4K |
| Q1 2023 | 17 | $187.3K |
| Q4 2022 | 23 | $243.7K |
| Q3 2022 | 25 | $575.4K |
| Q2 2022 | 39 | $1.18M |
| Q1 2022 | 41 | $1.80M |
| Q4 2021 | 45 | $2.57M |
| Q3 2021 | 42 | $3.45M |
| Q2 2021 | 45 | $26.0M |
| Q1 2021 | 50 | $11.2M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Iterum Therapeutics plc; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 10,795 | $539 | 0.00% | +10,795 | New |
| Cypress Capital Management LLC (WY) | 66 | $3 | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 0 | $0 | 0.00% | −890,083−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −138,600−100.0% | Sold out |
| Gen-Wealth Partners Inc | 0 | $0 | 0.00% | −82,617−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −72,156−100.0% | Sold out |
| Krilogy Financial LLC | 0 | $0 | 0.00% | −69,761−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −49,380−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −33,464−100.0% | Sold out |
| Flagship Harbor Advisors, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −15,713−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,201−100.0% | Sold out |
| Medallion Wealth Advisors, LLC | 0 | $0 | 0.00% | −1,680−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −993−100.0% | Sold out |
| Activest Wealth Management | 0 | $0 | 0.00% | −133−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −85−100.0% | Sold out |
| Blue Bell Private Wealth Management, LLC | 0 | $0 | 0.00% | −66−100.0% | Sold out |
| Robinswood Financial LLC | 0 | $0 | 0.00% | −66−100.0% | Sold out |